Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
- PMID: 30543310
- DOI: 10.1177/0004867418815982
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
Comment on
-
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.Am J Psychiatry. 2018 Mar 1;175(3):225-231. doi: 10.1176/appi.ajp.2017.17030325. Epub 2017 Dec 15. Am J Psychiatry. 2018. PMID: 29241357 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical